4Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high - sensitivity assays [J]. J Cardiol, 2012, 60 (3) : 160 - 167.
5Body R, Carley S, McDoweU G, ct al. Rapid exclusion of acute myo- cardial itffarction in patients with undetectable troponin using a high - sensitivity assay [J]. J Am Coil Cardiol, 2011, 58 (13) : 1332 - 1339.
6Metra M, Bettari L, Pagani F, et al. Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their de- tection and release during hospitalization [J]. Clin Res Cardiol, 2012, 101 (8): 663-672.
7de Antonio M, Lupon J, Galan A, et al. Combined use of high - sen- sitivity cardiac treponin T and N - terminal pm - B type natriuretic pep- tide improves measurements of performance over established mortality risk factors in chronic heart failure [J]. Am Heart J, 2012, 163 (5) :821 -828.
8Pascual - Figal DA, Casas T, Ordonez - Llanos J, et al. Highly sensi- tive troponin T for risk stratification of acutely destabilized heart failure [J]. Am HeartJ, 2012, 163 (6): 1002-1010.
9Melki D, Lind S, Agewall S, et al. Prognostic value of combining high sensitive troponin T and N - terminal pro B - type natriuretic pep- tide in chest pain patients with no persistent ST- elevation [ J]. Clin Chim Acta, 2012, 413 (9/10): 933-937.
10Jungbauer CG, Riedlinger J, Buchner S, et al. High - senstive tro- ponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis indepently from N - terminal pro- b- type natricuretic peptide [ J]. Clin Chem Lab Med, 2011, 49 (11): 1899 -1906.
